Group 1 - CorMedix (CRMD) shares have increased by 21.4% over the past four weeks, closing at $14.64, with a mean price target of $19.33 indicating a potential upside of 32% [1] - The average price targets from analysts range from a low of $17.00 to a high of $21.00, with a standard deviation of $1.37, suggesting a relatively high agreement among analysts [2] - Analysts are optimistic about CRMD's earnings prospects, as indicated by a 53.6% increase in the Zacks Consensus Estimate for the current year over the past month [10][11] Group 2 - The Zacks Rank for CRMD is 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [11] - There is a strong correlation between trends in earnings estimate revisions and near-term stock price movements, supporting the expectation of an upside in CRMD [9]

Core Viewpoint - OppFi Inc. (OPFI) shows potential for significant upside, with a mean price target of $14 indicating a 36.1% increase from the current price of $10.29 [1] Price Target Analysis - The average price target consists of three estimates ranging from $12.50 to $16.00, with a standard deviation of $1.8, suggesting a variability in analyst predictions [2] - The lowest estimate indicates a 21.5% increase, while the highest suggests a 55.5% upside [2] - A low standard deviation indicates a strong agreement among analysts regarding the price movement direction [7] Earnings Estimates - Analysts are optimistic about OPFI's earnings prospects, with a consensus indicating higher earnings estimates compared to previous predictions [4][9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 15.5%, with two estimates moving higher and no negative revisions [10] Zacks Rank - OPFI holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the extent of OPFI's potential gains, it does provide a useful guide for the direction of price movement [12]

Group 1 - Solaris Resources Inc. (SLSR) shares have increased by 7.7% over the past four weeks, closing at $5.34, with a mean price target of $10.73 indicating a potential upside of 100.9% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $2.13, where the lowest estimate of $8.76 suggests a 64% increase, and the highest estimate of $13.05 indicates a 144.4% surge [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as indicated by a 34.3% increase in the Zacks Consensus Estimate for the current year [9][10] Group 2 - The Zacks Rank for SLSR is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [11] - While price targets can provide insights, they should be approached with skepticism, as they may not reliably indicate actual stock price movements [8][12] - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated expectations [6]

Core Viewpoint - Edgewise Therapeutics, Inc. (EWTX) shows significant upside potential with a mean price target of $39.17, indicating a 173% increase from its last trading price of $14.35 [1][11]. Price Targets and Analyst Consensus - The average price target for EWTX is based on 12 short-term estimates, ranging from a low of $14.00 to a high of $51.00, with a standard deviation of $12.96, suggesting variability in analyst predictions [2][9]. - The lowest estimate indicates a potential decline of 2.4%, while the highest suggests a 255.4% upside [2]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about EWTX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11]. - The Zacks Consensus Estimate for the current year has risen by 9.1% over the past month, with eight estimates increasing and no negative revisions [12]. - EWTX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, as empirical research indicates that they rarely predict actual stock price movements accurately [7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].

Group 1 - SiriusPoint (SPNT) closed at $18.72, with a 1.8% gain over the past four weeks, and a mean price target of $25 indicates a 33.6% upside potential [1] - The average price targets range from a low of $20.00 to a high of $30.00, with a standard deviation of $5, suggesting a variability in estimates [2] - Analysts show a strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 5.6% over the past month, with two estimates going higher and no negative revisions [12] - SPNT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Group 1 - ARKO Corp. shares have increased by 25.3% over the past four weeks, closing at $5, with a mean price target of $6.63 indicating a potential upside of 32.6% [1] - The mean estimate consists of four short-term price targets with a standard deviation of $2.21, where the lowest estimate is $4.50 (10% decline) and the highest is $9.00 (80% increase) [2] - Analysts show strong agreement on ARKO's ability to report better earnings, with a positive trend in earnings estimate revisions suggesting potential upside [4][11] Group 2 - The Zacks Consensus Estimate for ARKO's current year earnings has increased by 112.5% over the last 30 days, with no negative revisions [12] - ARKO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can indicate the direction of price movement [14]

Group 1: Stock Performance and Price Targets - Deluxe (DLX) closed at $19.66, with a 26.1% gain over the past four weeks, and a mean price target of $26.75 suggests a 36.1% upside potential [1] - The mean estimate includes four short-term price targets with a standard deviation of $2.75, indicating variability; the lowest estimate is $24.00 (22.1% increase), while the highest is $30.00 (52.6% increase) [2] - A tight clustering of price targets, represented by a low standard deviation, indicates high agreement among analysts about the stock's price movement direction [9] Group 2: Analyst Insights and Earnings Estimates - Analysts have shown increasing optimism about DLX's earnings prospects, with strong agreement in revising EPS estimates higher, which correlates with potential stock upside [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.2%, with one estimate moving higher and no negative revisions [12] - DLX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential upside [13] Group 3: Caution on Price Targets - While price targets are sought after by investors, they can often mislead; empirical research shows that they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should treat price targets with skepticism and not rely solely on them for investment decisions [10]

Group 1 - TTM Technologies (TTMI) shares have increased by 2.8% over the past four weeks, closing at $44.57, with a mean price target of $56.75 indicating a potential upside of 27.3% [1] - The mean estimate includes four short-term price targets with a standard deviation of $2.22, suggesting a consensus among analysts, with the lowest estimate at $55.00 (23.4% increase) and the highest at $60.00 (34.6% increase) [2] - Analysts show increasing optimism regarding TTMI's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for TTMI has increased by 0.2% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - TTMI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While the consensus price target may not be a reliable indicator of the extent of TTMI's gains, it does provide a directional guide for potential price movement [14]

Core Viewpoint - Hillman Solutions Corp. (HLMN) has seen a 27.5% increase in share price over the past four weeks, closing at $9.88, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $12.5, representing a 26.5% upside [1]. Price Targets - The average price target consists of eight short-term estimates ranging from a low of $10.00 to a high of $15.00, with a standard deviation of $1.77, indicating variability among analysts [2]. - The lowest estimate suggests a 1.2% increase from the current price, while the highest estimate indicates a potential upside of 51.8% [2]. Analyst Sentiment - Analysts show a consensus that HLMN will report better earnings than previously estimated, which strengthens the outlook for the stock [4]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 3.1%, with two estimates moving higher and no negative revisions [12]. Zacks Rank - HLMN currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [13]. Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to concerns about analysts' biases and the accuracy of their estimates [3][7][10]. - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9].

Group 1 - The Pennant Group, Inc. (PNTG) shares have increased by 8.8% over the past four weeks, closing at $24.01, with a mean price target of $33.6 indicating a potential upside of 39.9% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $5.13, where the lowest estimate is $28.00 (16.6% increase) and the highest is $40.00 (66.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 3.3% over the past month [11][12] Group 2 - PNTG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While consensus price targets are often viewed as important, they should be approached with skepticism as they may not reliably indicate actual stock price movements [10][14] - Analysts' price targets can be influenced by business relationships, leading to potentially inflated estimates, but a low standard deviation among targets suggests a consensus on price direction [8][9]